These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9752713)

  • 41. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbial contaminants in the interiors of spacecraft components.
    Opfell JB; Bandaruk W
    Life Sci Space Res; 1966; 4():133-65. PubMed ID: 11915885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ; Lieberman A; Abramson LR
    PDA J Pharm Sci Technol; 1994; 48(5):255-92. PubMed ID: 8000900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
    Korbutt GS
    Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents.
    Sing J; Erickson R; Fader R
    Gastrointest Endosc; 2006 Nov; 64(5):774-9. PubMed ID: 17055873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sterility control: basic mathematical considerations (author's transl)].
    Spicher G; Peters J
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):112-38. PubMed ID: 1179866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of terminal sterilization by irradiation on amber Type I and Type III glass containers containing veterinary oxytetracycline suspension.
    Wong J; Papadopoulos P; Rebbeck C; Schwabe S; Lischewski G; Melchert J; Kuu W; Agostinelli T; Smith T; Brame G; Lynn R; Hepler D
    PDA J Pharm Sci Technol; 2004; 58(1):6-14. PubMed ID: 15053050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction.
    Freitas S; Rudolf B; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2005 Oct; 61(3):181-7. PubMed ID: 16009542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gelatine production, the six steps to maximum safety.
    Schrieber R; Seybold U
    Dev Biol Stand; 1993; 80():195-8. PubMed ID: 8270109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hygienic precautions and microbiological quality control during the manufacturing of sterile drugs].
    Züge R
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 May; 176(2-3):134-41. PubMed ID: 7124163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An improved process for the production of sterile modified haemoglobin solutions.
    Highsmith FA; Driscoll CM; Chung BC; Chavez MD; Macdonald VW; Manning JM; Lippert LE; Berger RL; Hess JR
    Biologicals; 1997 Sep; 25(3):257-68. PubMed ID: 9324994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes.
    Sundaram S; Auriemma M; Howard G; Brandwein H; Leo F
    PDA J Pharm Sci Technol; 1999; 53(4):186-201. PubMed ID: 10754712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative terminal sterilization.
    Lindboe WG; Hayakawa K
    J Parenter Sci Technol; 1993; 47(3):138-41. PubMed ID: 8360807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.
    Jambon A; Forat M; Marchand C; Morel C; Merienne C; Filali S; Pirot F
    Eur J Hosp Pharm; 2024 Sep; ():. PubMed ID: 38789246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.